• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacologic concerns of corticosteroids in the treatment of patients with immune-related neuromuscular diseases.

作者信息

Dalakas M

机构信息

Neuromuscular Diseases Unit, NINDS, National Institutes of Health, Bethesda, Maryland.

出版信息

Neurol Clin. 1990 Feb;8(1):93-118.

PMID:2181270
Abstract

Traditionally, diseases affecting the motor unit had been subdivided based on anatomic criteria into diseases of the anterior horn cell, the peripheral nerve, the neuromuscular junction, and the muscle itself. For therapeutic considerations, however, a more precise cellular and clinicopathologic characterization of the diseases affecting the motor unit is needed. Based on the site and cell of the primary pathologic change, this article presents an immunotherapy-oriented broad classification of neuromuscular diseases affecting the motor unit.

摘要

相似文献

1
Pharmacologic concerns of corticosteroids in the treatment of patients with immune-related neuromuscular diseases.
Neurol Clin. 1990 Feb;8(1):93-118.
2
Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence-based data.皮质类固醇在神经肌肉疾病治疗中的应用:经验性数据与循证数据
Muscle Nerve. 2004 Jul;30(1):20-37. doi: 10.1002/mus.20075.
3
[ACTH and corticosteroid treatment for neurological diseases (author's transl)].
Nervenarzt. 1981 Aug;52(8):431-40.
4
Organ-specific autoantibodies with muscle weakness.伴有肌无力的器官特异性自身抗体。
Curr Opin Rheumatol. 1999 Nov;11(6):483-8.
5
An unsatisfactory report card.一份不尽人意的成绩单。
Acta Neurol Scand. 2009 Nov;120(5):368-9. doi: 10.1111/j.1600-0404.2009.01225.x.
6
[Prolonged therapeutic use of corticosteroids. Indications and risks].[皮质类固醇的长期治疗应用。适应症与风险]
Recenti Prog Med. 1980 Nov;69(5):531-50.
7
Adrenal therapy for neuromuscular disease including myasthenia gravis from 1896.自1896年起用于治疗包括重症肌无力在内的神经肌肉疾病的肾上腺疗法。
N Y State J Med. 1974 Oct;74(11):1974-6.
8
Classification of neuromuscular disorders.神经肌肉疾病的分类
Birth Defects Orig Artic Ser. 1971 Feb;7(2):18-37.
9
Corticosteroid therapy in pediatric practice.儿科实践中的皮质类固醇疗法。
Adv Pediatr. 1985;32:549-87.
10
Adverse effects of corticosteroid therapy in neuromuscular diseased patients are common and receive insufficient prophylaxis.皮质类固醇疗法在神经肌肉疾病患者中的不良反应很常见,且预防措施不足。
Acta Neurol Scand. 2009 Nov;120(5):364-7. doi: 10.1111/j.1600-0404.2009.01190.x.

引用本文的文献

1
Chronic inflammatory demyelinating polyneuropathy in childhood: clinical and electrophysiological features.儿童慢性炎症性脱髓鞘性多发性神经病:临床及电生理特征
Childs Nerv Syst. 1991 Aug;7(4):191-6. doi: 10.1007/BF00249394.